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Abstract 
Background: Many studies, almost all in an Endoscopic Retrograde 
Cholangiopancreatography (ERCP) setting, have been conducted to establish if 
a link exists between periampullary diverticula (PADs) and biliopancreatic 
diseases but the issue is still debated. 
Aims: The objective was to clarify the link between PADs and biliopancreatic 
disease, for the first time using Endoscopic Ultrasound (EUS). 
Methods: We retrospectively reviewed our database seeking patients scheduled 
for EUS with an indication that entailed the exploration of the second 
duodenum. For each patient with a PAD enrolled in the study, 6 controls were 
randomly selected.  
Results: 2475 patients met the inclusion criteria. Among them, 185 subjects with 
a PAD were found (prevalence 7.5%), 1110 subjects served as controls. 
Patients with a PAD had more frequently a history of cholangitis (8.1 vs 2.2%; 
OR 3.99, p<0.001), a higher prevalence of common bile duct (CBD) dilation 
(44.3 vs 28.2%; OR 2, p<0.0001) and a higher prevalence of CBD stones (34.1 
vs 19.6%; OR 2.1, p<0.0001). No differences were found about history of 
jaundice, acute/recurrent pancreatitis or EUS signs of chronic pancreatitis. 
Conclusion: Whereas PADs were linked with history of cholangitis, CBD stones 
and dilation, no association was found with pancreatic diseases.   
 
Keywords: choledocholithiasis; cholangitis; endosonography; pancreas. 
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Introduction 
Periampullary diverticula (PADs) are duodenal extraluminal mucosal 
outpouchings located within 2–3 cm from the ampulla of Vater. If the 
diverticulum does not involve the ampulla of Vater per se it is termed 
juxtapapillary diverticulum (JPD), if the papilla is located within the diverticulum 
it is termed intradiverticular papilla (IDP) [1]. 
   Most PADs are asymptomatic and found incidentally, but about 10% may be 
symptomatic and in 2% of cases they require surgical therapy. Complications 
include diverticulitis, haemorrhage, perforation [2]. The complications of the 
PADs are caused by inflammation or ulceration, or may arise from compression 
of the duodenal wall, the common bile duct (CBD) or the pancreatic duct due to 
the proximity to the engorged and distended diverticula. The potential effects of 
compression of the common bile duct include the formation of stones, pain and 
jaundice whereas the compression of the main pancreatic duct (MPD) may lead 
to acute and chronic pancreatitis [3]. 
   It is difficult to establish the real prevalence of the PADs in the general 
population: the studies report a prevalence between 0.16 and 27%, a variability 
strictly related to the method used for the diagnosis. The prevalence in studies 
using barium meals is 0.6-6% [1]; in autopsy studies is 23-32% [4], while in 
Endoscopic Retrograde Cholangiopancreatography (ERCP) series is 5-27% [1]. 
In consideration of the possible complications of ERCP, in the last 20 years, 
with the advent of Endoscopic Ultrasound (EUS), the diagnostic role of ERCP 
has been reduced.  
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   EUS performed with an oblique anterior viewing (that is a view intermediate 
between that of a gastroscope and of a duodenoscope) can easily detect PADs. 
Moreover, duodenal distension with water can allow echoendoscopic detection 
of PADs overlooked by endoscopic exploration. 
Furthermore, in the diagnosis of chronic pancreatitis, EUS has a great 
sensitivity because it can recognize the presence of minimal pancreatic 
structural changes and, due to its high-resolution power, is able to diagnose the 
presence of microliths that could be missed by other diagnostic modalities [5]. 
   With few exceptions [6,7] almost all Authors have found a causal relationship 
between PADs and lithiasis of the gallbladder and of the common bile duct [3,8-
19], instead there is debate on a link with pancreatic disease, with only few 
papers claiming an increased risk [20-22]. The existence of a possible 
association between PADs and pancreatic disease remains an unresolved 
issue. All previous studies were conducted using ERCP or radiological methods 
(CT or MRCP). Our study, for the first time, had the objective of clarifying the 
hypothesis of a link between PADs and biliopancreatic disease using EUS, a 
less risky diagnostic method than ERCP, with a comparable sensitivity in the 
diagnosis of PADs and higher sensitivity in detecting microliths and subtle 
pancreatic changes.  
 
Material and Methods  
We retrospectively reviewed our Institutional Review Board–approved EUS 
database seeking patients that underwent EUS from January 2001 to 
December 2014.  
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   Patients that had undergone EUS for an indication that required the 
exploration from the second duodenum were included: 
• biliary-pancreatic pathology: obstructive jaundice, biliary duct dilatation, 
cholangitis, increase of cholestasis enzymes, increase of pancreatic 
enzymes, biliary pain, pancreatitis 
• other indications: masses; neuroendocrine tumor; pancreatic cysts; 
polyps or submucosal lesions; ampulloma.  
   We excluded patients in whom, for anatomical reasons or previous surgical 
interventions (e.g., Billroth II gastric resection, pancreaticoduodenectomy), it 
was not possible to adequately visualize the papilla of Vater and patients in 
whom the test did not meet sufficient quality criteria (e.g., biliary or pancreatic 
stent that impaired the examination). We also excluded patients sent to perform 
EUS-guided fine needle aspiration (EUS-FNA), because in these patients, in 
which a diagnosis had already been made by another exam, the endoscopic 
and EUS exploration is more focused on the operative procedure rather than on 
a thorough investigation of the duodenum and neighbouring structures. 
   The diagnosis of cholangitis, acute and recurrent pancreatitis and obstructive 
jaundice was based on medical records. The diagnosis of CBD dilatation, 
choledocholithiasis, pancreatic duct dilatation was defined if present in the past 
medical history or found on EUS examination. 
   The diagnosis of chronic pancreatitis was made relying solely on EUS criteria 
(presence of at least five out of the nine well-known parenchymal and ductal 
criteria) [23]. 
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   Recurrent acute pancreatitis was defined by the occurrence of at least 3 
episodes of acute pancreatitis after exclusion of a possible chronic pancreatitis 
[24].  
   The presence of bile gallstones >1 mm was considered biliary lithiasis. 
   The CBD was considered dilated if the diameter was more than 7 mm with the 
gallbladder in situ and more than 10 mm after cholecystectomy. 
   The upper normal limit of the main pancreatic duct diameter in the pancreatic 
head was set at 3.6 mm. 
   A PAD was diagnosed when endoscopically detected or when it became 
visible, after filling the lumen with water, as an extroflexion of the duodenal wall 
containing aerial microbubbles (Figure 1). 
 
Figure 1. 
 
   The examinations were performed under conscious or deep sedation using 
radial echoendoscopes (GF UM 3, GF UM Q130, GF UM 160, GF UE 160) from 
Olympus (GmbH Hamburg, Germany) with a 50-55 degrees oblique viewing. All 
patients signed an informed consent before endoscopy. Three experienced 
endosonographers carried out the exams. It is our standardized practice to try 
to visualize endoscopically the papilla with the echoendoscope and then instil 
100-200 ml of water through the biopsy channel to fill and extend the duodenal 
lumen to visualize it endosonographically.  
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   The sample size was calculated based on the prevalence of idiopathic acute 
pancreatitis in periampullary extraluminal duodenal diverticula patients (13.7%) 
and in controls (1.8%) [21] and on the prevalence of relapsing or chronic 
pancreatitis (26% versus 14%) [20] obtained from the two studies in which a 
statistically significant difference resulted about pancreatic disease between 
patients with PAD and patients without PAD. Choosing the more stringent 
criterion, at least 103 patients with PAD and 618 patients without PAD were 
needed so that the study was adequately powered (for each patient with a PAD, 
6 subjects were randomly selected and served as the control group: this ratio 
between cases and controls seemed adequate to widely overcome the 
minimum number of patients required to obtain a sufficient statistical power, 
considering the number of cases found in our study).  
   On an Excel® spreadsheet we recorded demographic data, EUS findings and 
relevant clinical data (history of CBD dilation, cholangitis, choledocholithiasis, 
pancreatitis).  
 
Statistics 
Continuous variables were expressed as mean ± standard deviation (SD). The 
Chi-square, or Fisher’s exact test when appropriate, and the non-parametric 
Mann-Whitney U test were applied for categorical and continuous variables 
respectively. The multivariate analysis (Logistic regression) was performed to 
assess if the variables that were found statistically significant at the univariate 
analysis remained statistically significant after correction for age and gender 
biases. To calculate the required sample size of the two groups a type I error – 
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alpha of 0.05 and a type II error – beta of 0.2 were accepted. A p value of less 
than 0.05 was considered significant. A statistical software program (SPSS 
version 11.0, SPSS Inc., Chicago, IL) was employed. 
 
Ethical considerations 
All patients received a written information about the endoscopic procedure and 
gave informed consent for clinical data collection. The study protocol conforms 
to the ethical guidelines of the 1975 Declaration of Helsinki (6th revision, 2008) 
as reflected in a priori approval by the institution's human research committee. 
 
Results 
Two thousand four hundred seventy-five patients were included in the study. 
Among them, the presence of a PAD was diagnosed in 185 subjects 
(prevalence 7.5%). Among the 2290 patients without PADs, 1110 subjects were 
randomly selected and served as controls (6 controls were selected for each 
PAD patient) (Figure 2). 
 
Figure 2. 
 
   Patients with PADs were older than controls: mean age 69.8 ± 11.3 vs 61.4 ± 
13.9 years (p<0.0001); no statistically significant difference between PAD 
patients and controls was demonstrated about the gender (male/female = 
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89/96 among patients with PADs, 527/583 among patients without PADs, 
p = 0.94). 
   Data about biliary diseases are reported in Table 1. 
 
Table 1. 
 
   Regarding the data obtained from the clinical history, a higher prevalence of 
cholangitis was found in PAD patients than in controls (8.1% vs 2.2%, OR 3.99, 
p<0.0001).  
   Concerning the data resulting from the clinical history or from EUS, patients 
with PAD had a greater prevalence of dilatation of the CBD (44.3% vs. 28.2%, 
OR 2.03; p<0.0001) and a higher prevalence of choledocholithiasis (34% vs. 
19.6%, OR 2.11, p<0.0001) compared with controls. No statistically significant 
difference was found for the prevalence of obstructive jaundice. 
   Data about pancreatic disease are reported in Table 2. 
 
Table 2. 
 
   No statistically significant difference was found for the occurrence of acute, 
recurrent or chronic pancreatitis or pancreatic duct dilatation between PAD 
patients and controls. 
   Patients with PADs were further divided according to the location of the 
papilla of Vater with respect to the diverticulum [25]: 55/185 had a type I-PAD 
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(intradiverticular papilla), 64/185 type II (juxtapapillary diverticulum) and 66/185 
type III (periampullary diverticula). The three groups were similar for age and 
gender and no difference was found in the prevalence of biliopancreatic disease 
(Table 3). 
 
Table 3.  
 
Multivariate analysis   
A clinical history of cholangitis was present in 39 out of 1295 subjects (3.01%).     
   At logistic regression analysis, male gender and presence of PAD were 
statistically associated with cholangitis (p=0.03 and p=0.0006, respectively); 
conversely age was not a risk factor for cholangitis (p=0.09). The male gender 
gave a cholangitis OR of 2.08 (IC 95% = 1.07 - 4.07), the presence of PAD 
gave an OR of 3.35 (IC 95% = 1.67 - 6.68). 
   The dilatation of the CBD (either in the clinical history or found at EUS) was 
found in 517 out of 1295 subjects (39.9%). At logistic regression analysis the 
age and the presence of PAD were statistically associated with the dilatation of 
the CBD (p<0.0001 and p=0.009, respectively); on the contrary gender was not 
statistically associated with the dilatation of the CBD (p=0.94). An older age had 
a CBD dilatation OR of 1.04 (IC 95% = 1.03 - 1.05), the presence of PAD gave 
an OR of 1.55 (IC 95% = 1.12 - 2.14). 
   Choledocholithiasis was present (in the clinical history or found at EUS) in 337 
out of 1295 subjects (26%). At logistic regression analysis the age and the 
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presence of PAD were statistically associated with the dilatation of the CBD 
(p=0.004 and p=0.001, respectively); conversely no association was found with 
gender (p=0.62). A greater age gave a dilatation of the CBD OR of 1.01 (IC 
95% = 1 - 1.02), the presence of PAD had an OR of 1.9 (IC 95% = 1.37 - 2.67). 
 
Discussion 
Many Authors have investigated whether a link exists between PADs and 
biliopancreatic disease. The early studies were based on autopsy findings or 
barium meal. In the 80s ERCP became the first-choice method in the diagnostic 
and therapeutic evaluation of pancreas and biliary tract and the most recent 
studies on the topic were almost all conducted using this method (Table 4). 
 
Table 4 [3,6-10,12,14-16,18-22,26-44]. 
 
   In most of these studies a link was found between PADs and 
choledocholithiasis, but controversy exists about a relationship with CBD 
dilation, history of jaundice and acute cholangitis. 
   The pathological mechanism of this association is explained by several 
hypotheses. The mechanical pressure exerted by the diverticula on the distal 
part of the CBD is the most quoted mechanism. The larger the PAD and the 
closer it is to the papilla, the more it may disturb the bile flow [32]. Another 
hypothesis is related to the dysfunction of the sphincter of Oddi (SO), which is 
believed to be caused by the accumulation of food in the diverticula, 
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compressing the end of the bile duct as well as SO and leading to stricture of 
the sphincter [1]. 
   Some Authors claim that PADs may exert the same effect on the main 
pancreatic duct [45], but a link between PADs and pancreatic disease is far 
from being demonstrated: only few studies have addressed the topic and 
inconclusive results have been reached. 
   Uomo et al. [21], in a study conducted on 439 patients undergoing ERCP, 
showed a higher incidence of "idiopathic" acute pancreatitis among patients 
with diverticula than in patients without PAD, suggesting that this finding should 
be included in the possible causes of pancreatitis of unknown origin. However, 
the greater prevalence of pancreatitis as an indication to ERCP could be a bias. 
   The prevalence of PADs (7.5%) in our population was similar to that reported 
in the literature, even if a bit lower than the one found in an ERCP setting. The 
execution of ERCP, as a diagnostic or therapeutic method, is strictly related to a 
strong suspicion of biliopancreatic disease, and therefore it can be assumed 
that a higher prevalence of PADs can be due to a selection bias of the patients.     
   In other words, the prevalence we found could reflect the prevalence of PADs 
more accurately than in the studies conducted during ERCP. 
   From a demographic point of view, the previous studies have found a higher 
prevalence of PADs at an older age, while a clear gender correlation has not 
been demonstrated. Our results were consistent with the literature, showing that 
subjects with PADs were 8.4 years older than subjects without PADs, while no 
statistically significant differences were found for gender.  
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   As far as biliary disease is concerned, our data agree with most of the 
previous literature: indeed, we found a higher prevalence of CBD dilation, 
cholelithiasis and history of cholangitis among patients with PADs.  
   On the other hand, our data agree with the studies that deny the existence of 
an association between PADs and pancreatic pathology: we did not find a link 
with acute pancreatitis, chronic pancreatitis and recurrent pancreatitis. Since we 
have used, for the first time in the literature, a diagnostic method (EUS) with a 
high sensitivity in the diagnosis of minimal pancreatic changes, we can suppose 
that a relationship between PAD and, at least, chronic pancreatitis can be ruled 
out with reasonable certainty.  
   Some limitations of our study must be discussed. Unlike Ozogul et al. [25], we 
did not find that the type of diverticulum had an influence on the risk of biliary or 
pancreatic pathology, but we cannot be sure that our classification of PADs, 
based on the echoendoscopic or endoscopic images (but using an instrument 
with anterior oblique viewing and not a lateral one), has been completely 
accurate. In the same way, we cannot be sure we have not overlooked some 
PADs, but an estimate of the PADs prevalence was not the primary goal of our 
study. Due to the limitations of the method we used, it has not been possible to 
analyse the effect of the diverticulum diameter, as its measurement with EUS 
cannot be considered reliable because it is influenced by the degree of water 
filling, by the peristalsis, and by artefacts produced by air or ingests in its lumen.    
   As in almost all the published studies, we performed a retrospective analysis; 
this is in part compensated by the large number of patients we analyzed. The 
mean age of the PAD group was greater than that of the control group and this 
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might in part explain the greater risk for cholangitis, choledocholithiasis and 
CBD dilatation. To overcome this bias, an adjustment about the confounding 
variables (multivariate analysis) has been performed to adjust for age and 
gender confounding factors: the history of cholangitis did not result influenced 
by the age and the presence of PAD resulted statistically associated to the CBD 
dilation and the cholelithiasis also at the multivariate analysis. Finally, the 
missing data concerning the previous cholecystectomy and the presence of 
cholelithiasis prevented us not only to assess whether there is a relationship 
between PADs and gallbladder disease, but also to determine if the stones we 
found in the common bile duct had to be considered migrated from the 
gallbladder or originated in the CBD itself. Another bias, directly connected with 
the retrospective nature of the study, was that the patients may have omitted to 
recall a previous episode of acute pancreatitis or cholangitis, but every effort 
was made to minimize this problem by a thorough consultation of the clinical 
data of the patients.  
Finally, we did not analyse our data to asses if “old” echoendoscopes were less 
performant in terms of detection of subtle pancreatic changes than the “new” 
ones, but this possible bias in intrinsic in a study that spans so many years. 
   In conclusion, our study evaluated for the first time the prevalence of PADs 
with EUS. With this diagnostic modality we investigated the presence of a 
possible association with pancreatic and biliary disease.  We confirmed, in 
agreement with the existing literature, an association between diverticula and 
choledocholithiasis, cholangitis and common bile duct dilatation. No statistical 
association was found between PADs and acute, recurrent or chronic 
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pancreatitis or with pancreatic duct dilatation. In this context the study we 
conducted, using EUS, must be considered very reliable due to the high 
sensitivity of this technique in diagnosing minimal and initial changes in the 
pancreatic parenchyma and in the pancreatic ductal system.  Our results should 
be confirmed by prospective studies that will eliminate the bias of patients' 
omitted recall of a previous episode of acute pancreatitis, but this study is the 
first in the world that studied the clinical relevance of the occurrence of PAD 
with an EUS-approach. 
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Figure 1. EUS image of a periampullary diverticulum: external to the duodenal 
wall and next to the common bile duct (asterisk) the artefacts produced by air in 
the diverticulum are visible (dotted circle) 
Figure 2. Flow-chart of patient selection 
